New technology detects greater variety of T cells that respond to coronaviruses

Study finds 94 percent of patients with cancer respond well to COVID-19 vaccines

Chasing the cells that predict death from severe COVID-19

SARS-CoV-2 replication targets nasal ciliated cells early in COVID-19 infection